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Abstract 13 
A long wavelength TCF-based fluorescent probe (TCF-ALP) was developed for the detection of 14 
alkaline phosphatase (ALP). ALP-mediated hydrolysis of the phosphate group of TCF-ALP resulted 15 
in a significant fluorescence ‘turn on’ (58-fold), which was accompanied by a colorimetric response 16 
from yellow to purple. TCF-ALP was cell-permeable, which allowed it to be used to image ALP in 17 
HeLa cells. Upon addition of bone morphogenic protein 2, TCF-ALP proved capable of imaging 18 
endogenously stimulated ALP in myogenic murine C2C12 cells. Overall, TCF-ALP offers promise as 19 
an effective fluorescent/colorimetric probe for evaluating phosphatase activity in clinical assays or live 20 
cell systems.  21 
1 Introduction 22 
Alkaline phosphatase (ALP) is an ubiquitous enzyme found in the majority of human tissues, where it 23 
catalyses the dephosphorylation of various substrates such as nucleic acids, proteins and other small 24 
molecules (Millán, 2006, Coleman, 1992). ALP also plays an important role in signal transduction and 25 
regulation of intracellular processes (cell growth, apoptosis and signal transduction pathways) (Julien 26 
et al., 2011). Abnormal levels of ALP in serum are an indicator of several diseases including bone 27 
disease (Garnero and Delmas, 1993), liver dysfunction (Rosen et al., 2016), breast and prostatic cancer 28 
(Ritzke et al., 1998, Wymenga et al., 2001) and diabetes (Tibi et al., 1988). As a result, ALP is regarded 29 
as a key biomarker in medical diagnosis (Coleman, 1992, Ooi et al., 2007). Therefore, it is important 30 
to develop a fast, reliable and selective detection system for monitoring ALP activity that is amenable 31 
to clinical diagnostics.  32 
There have been numerous approaches to determine ALP levels, including colorimetric (Yang et al., 33 
2016, Hu et al., 2017), chemiluminescent (Jiang and Wang, 2012), electrochemical (Zhang et al., 34 
2015b), surface-enhanced Raman methods (Ruan et al., 2006) and fluorescence (Cao et al., 2016, Fan 35 
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et al., 2016). This work focused on the development of fluorescent probes for the detection of 36 
biologically relevant analytes (Sedgwick et al., 2017a, Sedgwick et al., 2018b, Wu et al., 2017, 37 
Sedgwick et al., 2017b, Sedgwick et al., 2018a, Zhang et al., 2019). Fluorescence has many advantages 38 
over other methods owing to its simplicity and high sensitivity/selectivity, providing rapid, non-39 
invasive, real-time detection (Wu et al., 2017). Whilst there have been many fluorophores developed 40 
for assaying ALP activity such as organic dyes (Zhang et al., 2015a, Zhao et al., 2017), conjugated 41 
polymers (Li et al., 2014), inorganic semiconductor dots (Qian et al., 2015), and noble metal clusters 42 
(Sun et al., 2014), most require high probe concentrations and crucially rely on short wavelength 43 
emission, thus limiting their applicability in biological systems. Therefore, ALP probes that operate at 44 
long wavelengths are urgently required. Such probes should allow for deeper tissue penetration and be 45 
subjected to less cell-based autofluorescence (Liu et al., 2017, Zhang et al., 2017, Tan et al., 2017).  46 
2 Results and Discussion 47 
2.1 Chemistry 48 
Here we report a TCF-based fluorescent probe that allows for the detection of ALP and/or ACP. As 49 
shown in Scheme 1, this probe (TCF-ALP) is based on the conjugation of 2-dicyanomethylene-3-50 
cyano-4,5,5-trimethyl-2,5-dihydrofuran (TCF) to an electron-donating moiety, a phosphorylated 51 
phenol; this affords an internal charge transfer (ICT) donor-π-acceptor (D-π-A) system whose 52 
fluorescence properties vary dramatically following ALP-mediated phosphate group cleavage 53 
(Gopalan et al., 2004, Liao et al., 2006, Lord et al., 2008, Bouffard et al., 2008, Jin et al., 2010, Teng 54 
et al., 2018, Sedgwick et al., 2017b). TCF-ALP was synthesised in four steps with an overall yield of 55 
27% (Scheme 2). In brief, 3-hydroxy-3-methyl-2-butanone, malononitrile and NaOEt were heated at 56 
reflux in EtOH for 1 h. The resultant precipitate TCF (1) was then treated with a mixture of piperidine 57 
(cat.) and 4-hydroxybenzaldehyde in EtOH to afford intermediate 2 (TCF-OH). Intermediate 2 was 58 
then treated with diethylchlorophosphate, DMAP (cat.) and NEt3 in THF to give the phosphonate ester 59 
3. Hydrolysis using trimethylsilyl iodide in dichloromethane (DCM) afforded TCF-ALP as a60 
crystalline solid (Et2O).61 
2.2 Spectroscopic studies of TCF-ALP 62 
UV-Vis and fluorescence spectroscopic titrations of TCF-ALP were performed in 50 mM Tris-HCl 63 
buffer in the absence and presence of ALP from porcine kidney. In the absence of ALP, TCF-ALP 64 
was found to have no UV absorption features above ~550 nm; however, upon addition of ALP a 65 
bathochromic shift in the UV absorption maximum was observed (from 440 to 580 nm), which was 66 
accompanied by a change in colour from yellow to purple (Figure S1). ALP-mediated hydrolysis of 67 
TCF-ALP to form highly fluorescent phenol (2), was confirmed by 31P NMR studies and HRMS (See 68 
Figure S1 – S4). The effect of pH on the rate of ALP mediated hydrolysis of TCF-ALP was evaluated. 69 
It was found that incubation with 0.8 U/mL of ALP at pH 9.2 resulted in the largest fluorescence 70 
response (Figure S5). Consequently, all in vitro experiments to determine ALP activity were carried 71 
out in 50 mM Tris-HCl buffer at pH 9.2.  72 
The kinetics of ALP towards TCF-ALP were determined via fluorescence spectroscopy (Figure S6 73 
and S7), with the resultant fluorescence data analysed using the Michaelis-Menten equation (Figure 74 
S8). This revealed a Km of 35.81 ± 2.63 µM and a Vmax of 3029 ± 157.3 min
-1 for hydrolysis of TCF-75 
ALP by ALP at pH 9.2 (see SI for details). TCF-ALP was then incubated with various concentrations 76 
of ALP (0.0 – 0.2 U/mL) for 15 minutes to evaluate its ability to monitor ALP activity. As shown in 77 
Figure 1, a significant fluorescence response was observed in the presence of ALP (58-fold) with a 78 
limit of detection (LOD) calculated as 0.12 mU/mL (Figure S9). This sensitivity is comparable to other 79 
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fluorescent probes found in literature (Table S3). Although serum alkaline phosphatase levels vary 80 
with age in normal individuals (Lowe et al., 2018), it is widely accepted that serum ALP levels in 81 
healthy adults lies between 39 – 117 U/mL (Sahran et al., 2018, Saif et al., 2005).  This suggests that 82 
TCF-ALP is capable of detecting ALP in human serum, and therefore could be used in clinical assays.  83 
Inhibition studies were carried out in the presence of sodium orthovanadate (Na3VO4), which is known 84 
to be a strong inhibitor of ALP activity. Addition of Na3VO4 resulted in a decrease in the fluorescence 85 
response in the TCF-ALP hydrolysis assay (see Figure S10) (Swarup et al., 1982). These inhibition 86 
studies enabled an IC50 of 6.23 µM to be calculated (Figure S11), which is similar in value to other 87 
ALP substrates that have been reported in the literature (Tan et al., 2017, Zhang et al., 2015a).  88 
The selectivity of TCF-ALP towards other biologically relevant enzymes (at their optimal pH values) 89 
was then determined (Figure 2 and S12), with TCF-ALP displaying high substrate selectivity for ALP 90 
over other common hydrolytic enzymes (e.g. trypsin, porcine liver esterase) or non-specific binding 91 
proteins (e.g. bovine serum albumin (BSA)). Interestingly, TCF-ALP produced a fluorescence 92 
response when treated with acid phosphatase (ACP). The detection of this enzyme is of significance 93 
since it is a tumour biomarker for metastatic prostate cancer (Makarov et al., 2009). Normal levels of 94 
ACP in serum range from 3.0 – 4.7 U/mL, and elevated ACP levels can be indicative of a variety of 95 
other diseases (Bull et al., 2002). Furthermore, TCF-ALP proved capable of detecting ACP (25-fold 96 
fluorescence enhancement) and ALP (38-fold enhancement) at a physiological pH of 7.1 (Figure S13 97 
and S14). Kinetic determination of ALP and ACP towards TCF-ALP at pH 7.1 was conducted, and 98 
the resultant Km and Vmax were compared (see SI 2.1 and Figures S15-S18). It was found that ALP has 99 
a smaller Km value in comparison to ACP (0.38 ± 0.042 µM and 99.22 ± 13.16 µM respectively) and 100 
a lower Vmax (208 ± 3.81 min
-1 and 1962 ± 223.6 min-1 respectively). Hence, ALP has higher affinity 101 
towards TCF-ALP compared to ACP, thus is more selective towards ALP at physiological pH. 102 
According to current standards, determination of ALP and ACP is undertaken at the phosphatase’s 103 
optimum pH. For example, the Centers for Disease Control and Prevention (CDC) procedure for ALP 104 
determination is carried out in 2-amino-2-methyl-1-propanol (AMP) buffer at pH 10.3 ((CDC), 2012). 105 
This is in accordance with other literature sources (Guo et al., 2018, Di Lorenzo et al., 1991, Radio et 106 
al., 2006, Pandurangan and Kim, 2015). Likewise, ACP determination is carried out at pH 4-6 (Myers 107 
and Widlanski, 1993, Boivin and Galand, 1986, LI et al., 1984). Following these observations, further 108 
studies were conducted to determine selectivity at pH 5.0 and 9.2 (Figures S19 – S22). Results showed 109 
that TCF-ALP acts selectivity towards ACP at acidic pH, and ALP at alkaline pH. Therefore, TCF-110 
ALP can be used to selectively detect ALP/ACP in clinical assays, or live cell systems (provided the 111 
buffer solution is optimal for the phosphatase under study). 112 
2.3 Imaging of ALP in living cells 113 
Prior to exploring whether TCF-ALP could be used to image ALP activity levels in live cells, the 114 
cytotoxicity of TCF-ALP was assessed using a MTT assay (Figure S23). Negligible cell toxicity was 115 
observed for TCF-ALP concentrations between 0 – 5 µM, and cell viability was only slightly reduced 116 
(91%) when incubated with 10 µM TCF-ALP, indicating good biocompatibility. 117 
TCF-ALP proved cell permeable to HeLa cells that express ALP and provided a clear ‘turn on’ 118 
response (Figure 3). In contrast, pre-treatment of HeLa cells with 5 mM Na3VO4 prior to incubation 119 
with TCF-ALP resulted in minimal ‘turn on’. This was taken as evidence that the increase in TCF-120 
ALP fluorescence levels seen for HeLa cells in the absence of Na3VO4 is due to ALP activity. We thus 121 
conclude TCF-ALP is a probe that allows for the selective cellular imaging of ALP activity. 122 
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Bone morphogenetic protein 2 (BMP-2) is capable of inducing osteoblast differentiation into a variety 123 
of cell types (Guo et al., 2014, Wang et al., 2015) via pathways that result in increased ALP mRNA 124 
expression, leading to increased ALP activity (Kim et al., 2004). Treatment of myogenic murine C2C12 125 
cells with TCF-ALP resulted in a low fluorescence intensity (low ALP levels) being observed (Figure 126 
4); however, pre-treatment of these cells with BMP-2 (300 ng/mL, 3 days) resulted in a significant 127 
increase in TCF-ALP-derived fluorescence intensity (high ALP levels). Once again, pre-incubation 128 
with 5 mM Na3VO4 led to no fluorescence response being observed in the cells treated with TCF-ALP 129 
(with or without BMP-2). This provided support for the notion that TCF-ALP is capable of imaging 130 
endogenous ALP activity induced by BMP-2. 131 
3 Conclusions 132 
In summary, a long wavelength TCF-based fluorescent probe (TCF-ALP) has been prepared with the 133 
goal of detecting ALP activity. ALP hydrolyses the phosphate group of TCF-ALP resulted in a 134 
significant ‘turn on’ fluorescence response (58-fold) within 15 minutes. These spectroscopic changes 135 
were accompanied by a colorimetric change from yellow to purple. This enables TCF-ALP to be used 136 
as a simple assay for the evaluation of ALP activity. Further analysis revealed that TCF-ALP could 137 
also be used as a probe for detecting ACP activity. TCF-ALP was shown to be cell permeable, enabling 138 
its use as a fluorescent probe for monitoring ALP levels in HeLa cells. TCF-ALP also proved capable 139 
of imaging endogenously stimulated ALP produced in myogenic murine C2C12 cells through the 140 
addition of bone morphogenetic protein 2. We thus suggest that TCF-ALP offers promise as a tool for 141 
measuring ALP and ACP activity levels in clinical assays or in live cell systems. 142 
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10 Captions for Figures and Schemes 297 
Scheme 1 – A TCF-based fluorescence probe (TCF-ALP) for the detection of alkaline phosphatase.  298 
Scheme 2 – Synthesis of TCF-ALP. 299 
Figure 1 - Fluorescence spectra of TCF-ALP (10 µM) produced via the addition of alkaline 300 
phosphatase (ALP; 0 – 0.2 U/mL) in 50 mM Tris-HCl buffer, pH = 9.2 at 25 °C. λex = 542-15 nm. All 301 
measurements were made 15 min after the addition of ALP. 302 
Figure 2 - Fluorescence spectra of TCF-ALP (10 µM) recorded in the presence of trypsin (0.8 BAEE 303 
U/mL), porcine liver esterase, protease from Streptomyces griseus, proteinase K, bovine serum 304 
albumin (0.1 mg/mL), acid phosphatase (50 mM Tris-HCl, pH = 5.0) and alkaline phosphatase (50 305 
mM Tris-HCl, pH = 9.2). All enzymes were standardised to 0.8 U/mL in Tris-HCl buffer pH 7.1 unless 306 
otherwise stated. λex = 542-15 nm/ λem = 606 nm. Fluorescence measurements were made 30 min after 307 
adding the enzyme in question. 308 
Figure 3 - HeLa cells incubated under the following conditions: (a) No treatment. (b) TCF-ALP (10 309 
μM, 30 min). (c) Pre-treated with Na3VO4 (5 mM, 30 min), followed by the addition of TCF-ALP (10 310 
μM, 30 min). (d) Pretreated with Na3VO4 (0.5 mM, 30 min) and TCF-ALP (10 μM, 30 min). Cells 311 
were washed with DPBS before their fluorescence images were acquired using a confocal microscope. 312 
Top half: fluorescence images, bottom half: fluorescence images merged with its corresponding DIC 313 
image. Ex. 559 nm/ em. 575-675 nm. Scale bar : 20 μm. DIC  - differential interference contrast. 314 
Figure 4- TCF-ALP in C2C12 cell. C2C12 cells were treated with 300 ng/mL BMP-2 for 3 days and 315 
then pretreated with 5 mM levamisole for 30 min and stained with 10 μM probe for 30 min. After 316 
washing with DPBS, fluorescence images were acquired by confocal microscopy. (a) only probe, (b) 317 
levamisole + probe, (c) BMP-2 + probe (d) BMP-2 + levamisole + probe. Top : fluorescence images, 318 
bottom : merged with DIC image. Ex. 559 nm/ em. 575-675 nm. Scale bar : 20 μm. DIC - differential 319 
interference contrast. 320 
In revi
ew
Figure 1.TIF
In revi
ew
Figure 2.TIF
In revi
ew
Figure 3.TIF
In revi
ew
Figure 4.TIF
In revi
ew
Figure 5.TIF
In revi
ew
Figure 6.TIF
In revi
ew
